Rilpivirine Hydrochloride
1 NDC across 1 manufacturer|0 Generic,1 Brand
Rilpivirine Hydrochloride is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 20, 2011, and the first generic was approved Jan 29, 2026. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient.
Rilpivirine Hydrochloride is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $48.04 to $48.04 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$48.04 – $48.04
per EA
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Janssen Products LP manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing RILPIVIRINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EDURANT 25 MG TABLET | $48.0410 per EA | -0.04% |
Frequently Asked Questions
What is Rilpivirine Hydrochloride used to treat?
Rilpivirine Hydrochloride is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
When did Rilpivirine Hydrochloride become available as a generic?
FDA approved the first generic Rilpivirine Hydrochloride (ANDA) on Jan 29, 2026. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Rilpivirine Hydrochloride products are on the market?
The Rilpivirine Hydrochloride drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Rilpivirine Hydrochloride?
NADAC reference prices for Rilpivirine Hydrochloride range from $48.0410 to $48.0410 per EA.
Which manufacturers make Rilpivirine Hydrochloride?
1 manufacturer lists Rilpivirine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Janssen Products LP (1).
How has the price of Rilpivirine Hydrochloride changed recently?
Over the past 7 days, 0 Rilpivirine Hydrochloride NDCs rose and 1 fell, with a market-wide average change of -0.0%.